麦角新碱联合缩宫素在瘢痕子宫剖宫产产妇中的应用效果

Abstract
Figure/Table
References (17)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the application effect of Ergometrine combined with Oxytocin in cesarean section of scarred uterus.Methods A total of 72 parturients with scar uterine cesarean section treated in our hospital from January 2018 to January 2019 were selected as the subjects,and divided into group A and group B by double-blind method,with 36 cases in each group.Group A was treated with Oxytocin alone,and group B was treated with Ergometrine combined with Oxytocin.The amount of bleeding,diastolic blood pressure,systolic blood pressure,total incidence of adverse reactions were observed in the two groups.Results The amount of bleeding in group B was less than that in group A after 2 and 24hours administration,and the differences were statistically significant (P<0.05).The diastolic pressure ([65±4] mmHg) and systolic pressure ([110±10] mmHg) of group B were lower than those of group A([68±7],[117±13] mmHg),with statistically significant differences (P<0.05).The incidence of adverse reactions in group B was 5.5%,lower than 33.3% in group A,and the difference was statistically significant (P<0.05).Conclusion In order to avoid postpartum hemorrhage of scarred uterus,Ergometrine combined with Oxytocin should be adopted to improve the treatment effect of patients and reduce the incidence of adverse reactions.

Key words： Ergometrine Intramuscular injection of lower uterine segment Scarred uterus Postpartum hemorrhage

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	FANG Li-mei
	KE Ying
	LIU Gui-rong

Cite this article:

FANG Li-mei,KE Ying,LIU Gui-rong. Application effect of Ergometrine combined with Oxytocin in cesarean section of scarred uterus[J]. 中国当代医药, 2020, 27(2): 100-102.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I2/100

[1]	卫蔷，张力，吴琳，等.麦角新碱联合卡贝缩宫素与单用缩宫素预防剖宫产产后出血研究[J].中国实用妇科与产科杂志，2018，34（6）：68-72.
[2]	张小红.马来酸麦角新碱与缩宫素预防高危产妇产后出血效果比较[J].中国药业，2017，26（14）：69-71.
[3]	张小梅.马来酸麦角新碱在子宫肌瘤剔除术中的临床应用观察[J].基层医学论坛，2018，529（13）：12-13.
[4]	张珍荣.马来酸麦角新碱注射液联合垂体后叶注射液治疗产后出血的临床疗效[J].中国实用医药，2018，13（15）：143-144.
[5]	宋小侠，卢燕玲，翁廷松，等.马来酸麦角新碱、卡贝缩宫素及卡前列素氨丁三醇预防和治疗宫缩乏力性产后出血效果的比较[J].广东医学，2017，38（18）：2850-2852.
[6]	张亚萍.三联疗法治疗宫缩乏力性产后出血疗效观察[J].临床医学研究与实践，2017，2（26）：126-127.
[7]	余虹.缩宫素联合欣母沛在瘢痕子宫产后出血及憩室中的预防效果及安全性研究[J].中国医学创新，2017，14（3）：99-101.
[8]	马晓兰，汪桂兰.卡前列甲酯栓与缩宫素联合预防瘢痕子宫产后出血的效果分析[J].中国现代药物应用，2017，11（5）：98-99.
[9]	张建梅.卡前列素氨丁三醇注射液联合缩宫素对妊娠晚期瘢痕子宫产后出血的影响[J].中国生化药物杂志，2017，37（9）：180-181.
[10]	梁昊，闫磊，韩新巍，等.髂外动脉造影在瘢痕子宫产后出血子宫动脉栓塞术中应用价值[J].介入放射学杂志，2018，27（5）：93-96.
[11]	崔文羡.卡前列素氨丁三醇注射液联合缩宫素治疗瘢痕子宫产后出血及憩室的效果观察[J].河南医学研究，2018，27（4）：689-690.
[12]	贺蓓.缩宫素联合欣母沛在瘢痕子宫产后出血及憩室中的预防效果[J].中国生化药物杂志，2017，37（10）：433-434.
[13]	蒲才秀，李秀泉，黄婵，等.手术干预控制60例瘢痕子宫再次剖宫产产后出血的疗效观察[J].重庆医学，2016，45（22）：3089-3090.
[14]	谢桃利.疤痕子宫剖宫产术中缩宫素联合欣母沛预防产后出血临床观察[J].医学理论与实践，2016，29（16）：2237-2238.
[15]	方芳，刘志茹，刘清.卡前列素氨丁三醇预防瘢痕子宫阴道分娩产后出血的效果及其对凝血功能的影响[J].实用临床医药杂志，2017，21（15）：142-143.
[16]	魏凌燕，王海霞.瘢痕子宫剖宫产术中用缩宫素联合马来酸麦角新碱预防产后出血的疗效[J].中国医药科学，2019，9（10）：112-114.
[17]	刘琼，赖慧超，钟华兰.新麦角新碱联合缩宫素在子宫瘢痕妊娠清宫术后的应用[J].中国当代医药，2019，26（7）：134-136.